218 related articles for article (PubMed ID: 20221403)
1. Phosphorylation of human tristetraprolin in response to its interaction with the Cbl interacting protein CIN85.
Kedar VP; Darby MK; Williams JG; Blackshear PJ
PLoS One; 2010 Mar; 5(3):e9588. PubMed ID: 20221403
[TBL] [Abstract][Full Text] [Related]
2. CIN85 regulates the ability of MEKK4 to activate the p38 MAP kinase pathway.
Aissouni Y; Zapart G; Iovanna JL; Dikic I; Soubeyran P
Biochem Biophys Res Commun; 2005 Dec; 338(2):808-14. PubMed ID: 16256071
[TBL] [Abstract][Full Text] [Related]
3. TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex.
Kim J; Kang D; Sun BK; Kim JH; Song JJ
Cell Signal; 2013 Jan; 25(1):372-9. PubMed ID: 23085457
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and down-regulation of epidermal growth factor receptors.
Kowanetz K; Szymkiewicz I; Haglund K; Kowanetz M; Husnjak K; Taylor JD; Soubeyran P; Engstrom U; Ladbury JE; Dikic I
J Biol Chem; 2003 Oct; 278(41):39735-46. PubMed ID: 12874286
[TBL] [Abstract][Full Text] [Related]
5. SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex.
Feng L; Wang JT; Jin H; Qian K; Geng JG
Cell Biochem Funct; 2011 Oct; 29(7):589-96. PubMed ID: 21830225
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.
Sato S; Zhao Y; Imai M; Simister PC; Feller SM; Trackman PC; Kirsch KH; Sonenshein GE
PLoS One; 2013; 8(10):e77288. PubMed ID: 24167568
[TBL] [Abstract][Full Text] [Related]
7. Interactions between the three CIN85 SH3 domains and ubiquitin: implications for CIN85 ubiquitination.
Bezsonova I; Bruce MC; Wiesner S; Lin H; Rotin D; Forman-Kay JD
Biochemistry; 2008 Aug; 47(34):8937-49. PubMed ID: 18680311
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of a novel adaptor protein, CIN85, that interacts with c-Cbl.
Take H; Watanabe S; Takeda K; Yu ZX; Iwata N; Kajigaya S
Biochem Biophys Res Commun; 2000 Feb; 268(2):321-8. PubMed ID: 10679202
[TBL] [Abstract][Full Text] [Related]
9. Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.
Haglund K; Schmidt MHH; Wong ES; Guy GR; Dikic I
EMBO Rep; 2005 Jul; 6(7):635-41. PubMed ID: 15962011
[TBL] [Abstract][Full Text] [Related]
10. The basic amino acids in the coiled-coil domain of CIN85 regulate its interaction with c-Cbl and phosphatidic acid during epidermal growth factor receptor (EGFR) endocytosis.
Zheng X; Zhang J; Liao K
BMC Biochem; 2014 Jul; 15():13. PubMed ID: 25005938
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the CIN85 adaptor protein and identification of components involved in CIN85 complexes.
Watanabe S; Take H; Takeda K; Yu ZX; Iwata N; Kajigaya S
Biochem Biophys Res Commun; 2000 Nov; 278(1):167-74. PubMed ID: 11071869
[TBL] [Abstract][Full Text] [Related]
12. Interactions of CCCH zinc finger proteins with mRNA. Binding of tristetraprolin-related zinc finger proteins to Au-rich elements and destabilization of mRNA.
Lai WS; Carballo E; Thorn JM; Kennington EA; Blackshear PJ
J Biol Chem; 2000 Jun; 275(23):17827-37. PubMed ID: 10751406
[TBL] [Abstract][Full Text] [Related]
13. Multimeric and differential binding of CIN85/CD2AP with two atypical proline-rich sequences from CD2 and Cbl-b*.
Ceregido MA; Garcia-Pino A; Ortega-Roldan JL; Casares S; López Mayorga O; Bravo J; van Nuland NA; Azuaga AI
FEBS J; 2013 Jul; 280(14):3399-415. PubMed ID: 23663663
[TBL] [Abstract][Full Text] [Related]
14. CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors.
Kowanetz K; Husnjak K; Höller D; Kowanetz M; Soubeyran P; Hirsch D; Schmidt MHH; Pavelic K; De Camilli P; Randazzo PA; Dikic I
Mol Biol Cell; 2004 Jul; 15(7):3155-66. PubMed ID: 15090612
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tristetraprolin deadenylation by poly(A) binding protein.
Rowlett RM; Chrestensen CA; Schroeder MJ; Harp MG; Pelo JW; Shabanowitz J; DeRose R; Hunt DF; Sturgill TW; Worthington MT
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G421-30. PubMed ID: 18467502
[TBL] [Abstract][Full Text] [Related]
16. CIN85 associates with TNF receptor 1 via Src and modulates TNF-alpha-induced apoptosis.
Narita T; Nishimura T; Yoshizaki K; Taniyama T
Exp Cell Res; 2005 Mar; 304(1):256-64. PubMed ID: 15707590
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and Structural Studies of the Interaction between ARAP1 and CIN85.
Li Q; Yang W; Wang Y; Liu W
Biochemistry; 2018 Apr; 57(14):2132-2139. PubMed ID: 29589748
[TBL] [Abstract][Full Text] [Related]
18. Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking.
Nonis D; Schmidt MHH; van de Loo S; Eich F; Dikic I; Nowock J; Auburger G
Cell Signal; 2008 Oct; 20(10):1725-39. PubMed ID: 18602463
[TBL] [Abstract][Full Text] [Related]
19. Novel insights into the mechanisms of CIN85 SH3 domains binding to Cbl proteins: solution-based investigations and in vivo implications.
Ababou A; Pfuhl M; Ladbury JE
J Mol Biol; 2009 Apr; 387(5):1120-36. PubMed ID: 19268472
[TBL] [Abstract][Full Text] [Related]
20. CD2BP3, CIN85 and the structurally related adaptor protein CMS bind to the same CD2 cytoplasmic segment, but elicit divergent functional activities.
Tibaldi EV; Reinherz EL
Int Immunol; 2003 Mar; 15(3):313-29. PubMed ID: 12618476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
